ISSN: 1885-5857 Impact factor 2023 7.2
Vol. 65. Num. 6.
Pages 559 (June 2012)

Summary of the Clinical Studies Reported in the Annual Scientific Sessions of the American College of Cardiology (Chicago, Illinois, United States, March 24–27, 2012)

Resumen de los ensayos clínicos presentados en las Sesiones Científicas Anuales del American College of Cardiology (Chicago. Illinois. Estados Unidos. 24–27 de marzo de 2012)

Pablo AvanzasaAntoni Bayes-GenisaLeopoldo Pérez de IslaaJuan SanchisaMagda Herasb

Options

Este artículo solo puede leerse en pdf
Bibliography
[1]
Bermejo J, Segovia J, Alfonso F..
Resumen de los ensayos clínicos presentados en las Sesiones Científicas Anuales de la American Heart Association (New Orleans. Estados Unidos, 8–12 de noviembre de 2008)..
Rev Esp Cardiol. , (2009), 62 pp. 178-187
[2]
Segovia J, Bermejo J, Alfonso F..
Resumen de los ensayos clínicos presentados en las Sesiones Científicas Anuales del American College of Cardiology (Orlando. Estados Unidos, 28–31 de marzo de 2009)..
Rev Esp Cardiol. , (2009), 62 pp. 660-669
[3]
Heras M, Bermejo J, Segovia J, Alfonso F..
Resumen de los ensayos clínicos presentados en las sesiones científicas del Congreso de la Sociedad Europea de Cardiología (Barcelona España, 29 de agosto-2 de septiembre de 2009)..
Rev Esp Cardiol. , (2009), 62 pp. 1149-1160
[4]
Pérez de Isla L, Bayes-Genis A, Sanchis J, Heras M..
Resumen de los ensayos clínicos presentados en las Sesiones Científicas Anuales de la American Heart Association (Orlando Estados Unidos, 14–18 de noviembre de 2009)..
Rev Esp Cardiol. , (2010), 63 pp. 190-199
[5]
Pérez de Isla L, Bayes-Genis A, Sanchis J, Heras M..
Resumen de los ensayos clínicos presentados en las Sesiones Científicas Anuales del American College of Cardiology (Atlanta Estados Unidos, 14–16 de marzo de 2010)..
Rev Esp Cardiol. , (2010), 63 pp. 695-707
[6]
Bayes-Genis A, Avanzas P, Pérez de Isla L, Sanchis J, Heras M..
Resumen de estudios clínicos presentados en el Congreso de 2010 de la European Society of Cardiology (28 de agosto-1 de septiembre de 2010, Estocolmo Suecia)..
Rev Esp Cardiol. , (2010), 63 pp. 1292-1303
[7]
Avanzas P, Bayes-Genis A, Pérez de Isla L, Sanchis J, Heras M..
Resumen de los ensayos clínicos presentados en las Sesiones Científicas Anuales de la American Heart Association (Chicago Estados Unidos, 13–17 de noviembre de 2010)..
Rev Esp Cardiol. , (2011), 64 pp. 59.e1-59.e8
[8]
Avanzas P, Pérez de Isla L, Bayes-Genis A, Sanchis J, Heras M..
Resumen de los ensayos clínicos presentados en las Sesiones Científicas Anuales del American College of Cardiology (Nueva Orleans, Luisiana Estados Unidos, 2–5 de abril de 2011)..
Rev Esp Cardiol. , (2011), 64 pp. 508.e1-508.e8
[9]
Avanzas P, Bayes-Genis A, Pérez de Isla L, Sanchis J, Heras M..
Resumen de estudios clínicos presentados en el Congreso de 2011 de la European Society of Cardiology (27–30 de agosto de 2011, París, Francia)..
Rev Esp Cardiol. , (2011), 64 pp. 1011.e1-1011.e8
[10]
Avanzas P, Bayes-Genis A, Pérez de Isla L, Sanchis J, Heras M..
Resumen de los ensayos clínicos presentados en las Sesiones Científicas Anuales de la American Heart Association (Orlando, Estados Unidos, 12–16 de noviembre de 2011)..
Rev Esp Cardiol. , (2012), 65 pp. 71.e1-71.e9
[11]
Aversano T, Lemmon CC, Liu L. for the Atlantic CPORT Investigators. Outcomes of PCI at hospitals with or without on-site cardiac surgery. N Engl J Med. 2012 [Epub ahead of print March 25] [citado 27 Mar 2012]. DOI: 10.1056/NEJMoa1114540. Available at: http://www.nejm.org/doi/full/10.1056/NEJMoa1114540?query=featured_home..
[12]
Stone GW, Maehara A, Witzenbichler B, Jacek Godlewski J, Parise H, Dambrink JHE, et al. Intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction. The INFUSE-AMI randomized trial. JAMA. 2012 March 25 [accesed 27 Mar 2012]. DOI: 10.1001/jama.2012.421. Available at: http://jama.ama-assn.org/content/early/2012/03/21/jama.2012.421.full..
[13]
Randomized comparison of adding cilostazol versus doubling the dose of clopidogrel after receiving percutaneous coronary intervention: The HOST-ASSURE Randomized Trial. Presented by Kyung Woo Park at the ACC.12/i2 Summit, Chicago, Ill, March 25, 2012. Available at: http://my.americanheart.org/idc/groups/ahamahpublic/@wcm/@sop/@scon/documents/downloadable/ucm_438682.pdf..
[14]
Kodali SK, Williams MR, Smith CR, Svensson LG, Webb JG, Makkar RR, et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med. 2012 March 26 [accesed 28 Mar 2012]. DOI: 10.1056/NEJMoa1200384. Available at: http://www.nejm.org/doi/full/10.1056/NEJMoa1200384?query=featured_home..
[15]
Morrow DA, Braunwald E, Bonaca MP, Ameriso SF, Dalby AJ, Fish MP, et al. Vorapaxar in the secondary prevention of atherothrombotic events. N Engl J Med. 2012 March 24[accesed 27 Mar 2012]. DOI: 10.1056/NEJMoa1200933. Available at: http://www.nejm.org/doi/full/10.1056/NEJMoa1200933?query=featured_home - t=abstract..
[16]
Schauer PR, Kashyap SR, Wolski K, Brethauer SA, Kirwan JP, Pothier CE, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012 March 26 [accesed 28 Mar 2012]. DOI: 10.1056/NEJMoa1200225. Available at: http://www.nejm.org/doi/full/10.1056/NEJMoa1200225?query=featured_home..
[17]
Long-term reduction in LDL-C early in life. Presented by Brian Anthony Ference at the ACC.12/i2 Summit, Chicago, Ill, March 26, 2012. Available at: http://my.americanheart.org/idc/groups/ahamah-public/@wcm/@sop/@scon/documents/downloadable/ucm_438685.pdf..
[18]
McKenney JM, Koren MJ, Kereiakes DJ, Hanotin C, Ferrand AC, Stein EA. A randomized, double-blind, placebo-controlled trial of the safety and efficacy of a monoclonal antibody to PCSK9, SAR236553/REGN727, in patients with primary hypercholesterolemia. Presented by James M. McKenney at the ACC.12/i2 Summit, Chicago, Ill, March 28, 2012. Available at: http://my.americanheart.org/idc/groups/ahamah-public/@wcm/@sop/@scon/documents/downloadable/ucm_438651.pdf..
[19]
Berwanger O, Guimarães HP, Laranjeira LN, Cavalcanti AB, Kodama AA, Zazula AD, et al. Effect of a multifaceted intervention on use of evidence-based therapies in patients with acute coronary syndromes in Brazil. The BRIDGE-ACS Randomized Trial. JAMA. 2012 March 25 [citado 27 Mar 2012]. DOI: 10.1001/jama.2012.413. Available at: http://jama.ama-assn.org/content/early/2012/03/21/jama.2012.413.full..
[20]
Litt HI, Gatsonis C, Snyder B, Singh H, Miller CD, Entrikin DW, et al. CT angiography for safe discharge of patients with possible acute coronary syndromes. N Engl J Med. 2012 March 26 [citado 28 Mar 2012]. DOI: 10.1056/NEJMoa1201163. Available at: http://www.nejm.org/doi/full/10.1056/NEJMoa1201163?query=featured_home..
[21]
ROMICAT II- Rule OUT Myocardial Ischemia/Infarction Using Computer Assisted Tomography. Presented by Udo Hoffmann at the ACC.12/i2 Summit, Chicago, Ill, March 28, 2012. Available at: http://my.americanheart.org/idc/groups/ahamahpublic/@wcm/@sop/@scon/documents/downloadable/ucm_438649.pdf..
[22]
Selker HP, Beshansky JR, Sheehan PR, Massaro JM, Griffith JL, D’Agostino RB, et al. Outof-hospital administration of intravenous glucose-insulin-potassium in patients with suspected acute coronary syndromes. The IMMEDIATE randomized controlled trial. JAMA. 2012 March 27 [citado 27 Mar 2012]. DOI: 10.1001/jama.2012.426. Available at: http://jama.ama-assn.org/content/early/2012/03/21/jama.2012.426.full..
[23]
Lamy A, Devereaux PJ, Prabhakaran D, Taggart DP, Hu S, Paolasso E, et al. Off-pump or on-pump coronary-artery bypass grafting at 30 days. N Engl J Med. 2012 March 26 [accesed 26 Mar 2012]. DOI: 10.1056/NEJMoa1200388. Available at: http://www.nejm.org/doi/full/10.1056/NEJMoa1200388?query=featured_home..
[24]
Weintraub WS, Grau-Sepulveda MV, Weiss JM, O’Brien SM, Peterson ED, Kolm P, et al. Comparative effectiveness of revascularization strategies. N Engl J Med. 2012 March 27 [accesed 28 Mar 2012]. DOI: 10.1056/NEJMoa1110717. Available at: http://www.nejm.org/doi/full/10.1056/NEJMoa1110717?query=featured_home#t=abstract..
[25]
The EINSTEIN-PE Investigators. Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med. 2012 March 26 [accesed 28 Mar 2012]. DOI: 10.1056/NEJMoa1113572. Available at: http://www.nejm.org/doi/full/10.1056/NEJMoa1113572?query=featured_home#t=articleBackground..
[26]
Moderate Pulmonary Embolism Treated with Thrombolysis 26 (MOPETT Study). Presented by Mohsen Sharifi at the ACC.12/i2 Summit, Chicago, Ill, March 28, 2012. Available at: http://my.americanheart.org/idc/groups/ahamah-public/@wcm/@sop/@scon/documents/downloadable/ucm_438752.pdf..
[27]
Perin EC, Willerson JT, Pepine CJ, Henry TD, Ellis SG, Zhao DXM, et al. Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure. The FOCUS-CCTRN Trial. JAMA. 2012 March 24 [accesed 27 Mar 2012]. DOI: 10.1001/jama.2012.418. Available at: http://jama.ama-assn.org/content/early/2012/03/21/jama.2012.418.ful..
[28]
Pacemaker therapy in patients with neurally-mediated syncope and documented asystole. ISSUE 3 Trial. Presented by Michele Brignole at the ACC.12/i2 Summit, Chicago, Ill, March 26, 2012 [accesed 28 Mar 2012]. Available at: http://my.americanheart.org/idc/groups/ahamah-public/@wcm/@sop/@scon/documents/downloadable/ucm_438684.pdf..
Are you a healthcare professional authorized to prescribe or dispense medications?